Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.

Cell metabolism - 2 Mar 2021

Drucker Daniel J

Abstract excerpt

The increased prevalence of obesity, diabetes, and cardiovascular risk factors in people hospitalized with severe COVID-19 illness has engendered considerable interest in the metabolic aspects of SARS-CoV-2-induced pathophysiology. Here, I update concepts informing how metabolic disorders and their co-morbidities modify the susceptibility to, natural history, and potential treatment of SARS-CoV-2 infection, with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme 2
Share to Cholesterol
Share to Comorbidity

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to COVID-19 Drug Treatment

Share to Diabetes Mellitus

Share to Heart Disease Risk Factors

Share to Hyperglycemia

Share to Metabolic Diseases

Source

Open in PubMed Open full text

Identifiers

PMID: 33529600
DOI: 10.1016/j.cmet.2021.01.016
PMCID: PMC7825982

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.PMID 33529600Read ↗

Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care.Semantic proximity Read ↗

Regulation of angiotensin converting enzyme 2 (ACE2) in obesity: implications for COVID-19Semantic proximity Read ↗

The impact of COVID-19 illness on metabolic phenotypes underlying type 2 diabetes mellitus: a systematic review.Semantic proximity Read ↗

Recent Progress in Metabolic Syndrome Research and TherapeuticsSemantic proximity Read ↗

The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers.Semantic proximity Read ↗

Obesity and its impact on COVID-19Semantic proximity Read ↗

Examination of the Complex Molecular Landscape in Obesity and Type 2 DiabetesSemantic proximity Read ↗

Metabolically healthy obesity: epidemiology, mechanisms, and clinical implicationsSemantic proximity Read ↗

An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and SeveritySemantic proximity Read ↗

Genetic Susceptibility of Type 2 Diabetes and Metabolic SyndromeSemantic proximity Read ↗

Replication of SARS-CoV-2 in Adipose Tissue Determines Organ and Systemic Lipid Metabolism in Hamsters and HumansSemantic proximity Read ↗

Diet induced obesity and type 2 diabetes drives exacerbated sex-associated disease profiles in K18-hACE2-mice challenged with SARS-CoV-2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.